SCN4A and hyperkalemic periodic paralysis: The Draggen mouse model of HyperPP carries an SCN4A gain‐of‐function mutation (I582V) in the skeletal muscle voltage‐gated sodium channel (Nav1.4), equivalent to that found in a patient with PP and myotonia (I588V).14